Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
Atsunori Tsuchiya, Suguru Takeuchi, Takayuki Watanabe, et al.
Inflammation and Regeneration (2019) Vol. 39, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 106
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
Zilong Zhang, Jin Shang, Qinyan Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 68
Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Wei‐Chen Huang, Yuan Li, Pin-Xuan Chen, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 70-80
Open Access | Times Cited: 110
Cell therapy for advanced liver diseases: Repair or rebuild
Benjamin J. Dwyer, Mark T. Macmillan, Paul Brennan, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 185-199
Open Access | Times Cited: 103
Influence of Microenvironment on Mesenchymal Stem Cell Therapeutic Potency: From Planar Culture to Microcarriers
Ang‐Chen Tsai, Richard Jeske, Xingchi Chen, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 83
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
Atsunori Tsuchiya, Suguru Takeuchi, Takahiro Iwasawa, et al.
Inflammation and Regeneration (2020) Vol. 40, Iss. 1
Open Access | Times Cited: 75
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
Suguru Takeuchi, Atsunori Tsuchiya, Takahiro Iwasawa, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine
Yasunari Matsuzaka, Ryu Yashiro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6480-6480
Open Access | Times Cited: 63
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
Samin Shokravi, Vitaliy Borisov, Burhan Abdullah Zaman, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
Takayuki Watanabe, Atsunori Tsuchiya, Suguru Takeuchi, et al.
Regenerative Therapy (2020) Vol. 14, pp. 252-261
Open Access | Times Cited: 69
Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling
Arezou Azizsoltani, Behzad Hatami, Mohammad Reza Zali, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115777-115777
Open Access | Times Cited: 18
Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases
Huikang Xu, Lijun Chen, Sining Zhou, et al.
World Journal of Stem Cells (2020) Vol. 12, Iss. 11, pp. 1276-1294
Open Access | Times Cited: 43
Regenerative medicine applications: An overview of clinical trials
Astgik Petrosyan, Paulo N. Martins, Kim Solez, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 24
Cell therapy in end-stage liver disease: replace and remodel
Xin-Hao Hu, Lan Chen, Hao Wu, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Therapeutic potential of mesenchymal stromal/stem cells in critical‐care patients with systemic inflammatory response syndrome
Gerardo J. Martí-Chillón, Sandra Muntión, Silvia Preciado, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
Dan Zhu, Zongbin Sun, Jiayun Wei, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3475-3495
Open Access | Times Cited: 5
Application of mesenchymal stem cell exosomes and their drug‐loading systems in acute liver failure
Shuqin Zhang, Yu Hou, Jing Yang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 13, pp. 7082-7093
Open Access | Times Cited: 37
Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1494-1494
Open Access | Times Cited: 36
Escherichia coli‐derived outer‐membrane vesicles induce immune activation and progression of cirrhosis in mice and humans
Kazuki Natsui, Atsunori Tsuchiya, Risa Imamiya, et al.
Liver International (2023) Vol. 43, Iss. 5, pp. 1126-1140
Closed Access | Times Cited: 12
The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers
Qianrong Wang, Xiangning Tang, Yu Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
Meruyert Dauletova, Hafsan Hafsan, Negah Mahhengam, et al.
Clinical Immunology (2021) Vol. 226, pp. 108712-108712
Open Access | Times Cited: 27
Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science
Faezeh Ebrahimi, Farzaneh Pirouzmand, Renzon Daniel Cosme Pecho, et al.
Biotechnology Progress (2023) Vol. 39, Iss. 6
Closed Access | Times Cited: 10
Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease
Foteini Korkida, Alexandra Stamatopoulou, Maria G. Roubelakis
Stem Cells Translational Medicine (2023) Vol. 13, Iss. 2, pp. 107-115
Open Access | Times Cited: 10
Research progress in stem cell therapy for Wilson disease
Xianlang Xiong, Ce Gao, Xiangying Meng, et al.
Regenerative Therapy (2024) Vol. 27, pp. 73-82
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top